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Abstract
Epidemiologists often use the potential outcomes framework to cast causal inference as
a missing data problem. Here, we demonstrate how bias due to measurement error can
be described in terms of potential outcomes and considered in concert with bias from
other sources. In addition, we illustrate how acknowledging the uncertainty that arises
due to measurement error increases the amount of missing information in causal infer-
ence. We use a simple example to show that estimating the average treatment effect
requires the investigator to perform a series of hidden imputations based on strong
assumptions.
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Introduction
Epidemiologists often wish to compare occurrence of an
outcome under different exposure scenarios, specifically to
attribute a causal effect to the difference in exposure condi-
tions. The comparison of interest in many studies is the
contrast between the expected value of an outcome if all
participants had been exposed and the expected value of
an outcome if no participants had been exposed, a contrast
which is often called the average treatment effect.1
To estimate the average treatment effect in this tutorial,
we use the potential outcomes framework central to the
counterfactual theory of causality proposed by Neyman2
and extended by Rubin3 and Robins.4 Potential outcomes
are the outcomes that participants would have experienced
Key Messages
• Using potential outcomes casts causal inference as a missing data problem.
• Bias due to measurement error can be incorporated into the potential outcomes framework.
• Considering measurement error in the potential outcomes framework acknowledges a greater extent of missing data
and more assumptions needed for causal inference.
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under a given exposure; accordingly, if an exposure is bin-
ary, a participant will have two potential outcomes (one
potential outcome had he been exposed and one potential
outcome had he been unexposed). The potential outcomes
framework casts causal inference as a missing data prob-
lem in which at least some of the potential outcomes are
missing.5
Biases due to confounding and loss to follow-up are
often described using potential outcomes (e.g. Hernan
20041), but bias due to measurement error is rarely framed
in these terms. Here, we illustrate how bias due to meas-
urement error can be described in terms of potential out-
comes and considered in concert with bias from other
sources.
The title of this paper begins ‘all your data are always
missing’. In a way, this title is incomplete: if it were not so
cumbersome, it could read, ‘even with no explicit missing
data, all of the information needed to identify the average
treatment effect is always missing’.6 We begin with the
premise that all of the potential outcomes are hidden. To
estimate the average treatment effect, we implicitly impute
the potential outcomes, and these imputations are based
on strong assumptions that are often untestable using the
observed data. Bias occurs when we impute the potential
outcomes incorrectly.
We illustrate these hidden imputations using a hypo-
thetical study population of HIV-seropositive participants.
The purpose of the hypothetical study is to estimate the ef-
fect of injection drug use (X) on continuous CD4 count (in
units of cells/mm3) 1 year after initiation of antiretroviral
therapy (Y). Here we illustrate bias due to exposure meas-
urement error, confounding by the unmeasured variable U,
and selection bias using the potential outcomes frame-
work. Although important, we save discussion of out-
come and covariate measurement error for the Discussion.
Table 1 provides a guide to the notation used in the paper,
and Figure 1 provides a causal diagram illustrating the re-
lationships between the variables.
Example data
Tables 2, 3 and 4 present the example data, with each sub-
sequent table showing the influence of a new type of bias
on the estimate of the effect of injection drug use on CD4
cell count. Table 2 shows the complete (but hidden) data
for 600 participants. An unmeasured time-fixed con-
founder U is associated with injection drug use (individuals
with U¼ 1 have half the probability of being an injection
drug user as participants with U¼ 0) and has an effect on
CD4 cell count; in fact, one could describe the expected
CD4 cell count as E Y x;uð Þ½  ¼ 370 120x 130u. U is
not affected by X and the effect of X on Y is homogeneous
with regard to U. Participants are grouped into four rows
(‘groups’) defined by their true exposure X and unmeas-
ured confounder U. Participants are grouped in such a
manner only to avoid creating a table with a separate row
for each participant, which would have been unwieldy at
600 rows. Because, in this simple example, average
CD4 cell count is determined by U and X, the average
observed outcome Y is distinct for each row in Table 2.
However, within each group, all participants share an ex-
pected value of Y.
To illustrate the missing data implicit in all epidemiolo-
gical analyses, we adopt the notation of potential out-
comes.2,3 The third and fourth columns of Table 2 provide
the average of the unobserved potential outcomes for par-
ticipants in each row. Because exposure has two levels,
there are two potential outcomes for each participant. The
notation Yðx ¼ 0Þ represents the potential CD4 cell count
for a participant had he been unexposed, and Yðx ¼ 1Þ
represents the potential CD4 cell count for the same par-
ticipant had he been exposed. The causal effect of interest
Table 1. Notation
Type Symbol Meaning
Hidden Y(x¼1) Potential CD4 cell count 1 year after therapy initiation had the participant been exposed to injection drug use
Y(x¼0) Potential CD4 cell count 1 year after therapy initiation had the participant never been exposed to injection drug use
X True injection drug use status
U Unmeasured confounder of the injection drug use—CD4 cell count relationship
Observed Y CD4 cell count 1 year after therapy initiation
X’ Participant-reported injection drug use
C Indicator of loss to follow-up during the study period
Imputed X* Injection drug use status assumed to be true in the analysis
Y(x¼1)* Potential CD4 cell count 1 year after therapy initiation had the participant been exposed to injection
drug use imputed during the analysis
Y(x¼0)* Potential CD4 cell count 1 year after therapy initiation had the participant never been exposed to
injection drug use imputed during the analysis
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is the average contrast in potential outcomes had all par-
ticipants been exposed and had all participants been unex-
posed or, more succinctly, E Y x ¼ 1ð Þ  Y x ¼ 0ð Þ½ .
Throughout the paper, we use the difference of the poten-
tial outcomes as the contrast of interest and we treat poten-
tial outcomes as deterministic, rather than stochastic.
Based on the hidden potential outcomes presented
in Table 2, we can calculate the true average causal effect
E Y x ¼ 1ð Þ  Y x ¼ 0ð Þ½  ¼ 120 cells/mm3. Note that the
magnitude of the potential outcomes is determined by U,
and there is no effect heterogeneity by U or X; exposure
has the same average effect E½Y x ¼ 1ð Þ  Y x ¼ 0ð Þ
¼120 cells/mm3) in each group. We compute the true aver-
age causal effect as the average of the difference in potential
outcomes under exposure and no exposure in each group,
weighted by the number of participants in that group.
Because the average causal effect was the same in each group,
this calculation was quite simple: ½100ð120Þ þ 100ð120Þ
þ200ð120Þ þ 200ð120Þ=ð100 þ 100þ 200 þ 200Þ ¼
120.
The rightmost three columns of Table 2 present the
exposures and outcomes (X
0
and Y, respectively) that would
have been observed in this hypothetical study with no loss
to follow-up or measurement error. The average observed
outcome Y is provided in the rightmost column of Table 2.
If X¼0, we observe the potential outcome Y x ¼ 0ð Þ and, if
X¼1, we observe the potential outcome Y x ¼ 1ð Þ.
Accordingly, the average observed outcome for each group
is E Y x ¼ 0ð Þ½  if X ¼ 0 and E Y x ¼ 1ð Þ½  if X ¼ 1.
We often estimate the association between X and Y as
the difference in the expected value of Y between
Table 2. Unobserved potential outcomes and observed aver-
age CD4 cell counts in cells/mm3 (Y) for 600 participants in a
hypothetical study (300 injection drug users (X ¼ 1), 300 par-
ticipants who do not inject drugs (X ¼ 0)) with confounding
by unmeasured variable U, divided into four groups based
on X and U
Group n Hidden Observed
Average potential outcome U X n X
0a E(Y)
E[Y(x¼1)] E[Y(x¼0)]
1 100 120 240 1 1 100 1 120
2 100 250 370 0 0 100 0 370
3 200 120 240 1 0 200 0 240
4 200 250 370 0 1 200 1 250
aX0 is the observed injection drug use status. In this table, X0 ¼X because
X is measured without error here.
Table 4. As in Table 3, but with 80% sensitivity and 80% speci-
ficity for exposure classification that is nondifferential with
respect to the outcome
Group n Hidden Observed
Average potential outcome U X n X0 C E(Y)
E[Y(x¼1)] E[Y(x¼0)]
1 100 120 240 1 1 80 1 0 120
20 0 0 120
2 100 250 370 0 0 80 0 0 370
20 1 0 370
3 200 120 240 1 0 160 0 0 240
40 1 0 240
4 200 250 370 0 1 80 1 0 250
20 0 0 250
80 1 1 ?
20 0 1 ?
aX0 is the observed injection drug use status. In this table, X0 does not al-
ways equal X because X is sometimes measured with error.
Figure 1. Causal diagram representing the relationships between vari-
ables for 600 participants in a hypothetical study [300 injection drug
users (X ¼ 1), 300 participants who do not inject drugs (X ¼ 0)] with
confounding by unmeasured variable U, loss to follow-up (C), and non-
differential misclassification of X.
Table 3. As in Table 2, but with 50% loss to follow-up (C)
among those with U¼0 and X¼1
Group n Hidden Observed
Average potential outcome U X n X
0a C E(Y)
E[Y(x¼1)] E[Y(x¼0)]
1 100 120 240 1 1 100 1 0 120
2 100 250 370 0 0 100 0 0 370
3 200 120 240 1 0 200 0 0 240
4 200 250 370 0 1 100 1 0 250
100 1 1 ?
aX0 is the observed injection drug use status. In this table, X0 ¼X because
X is measured without error here.
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participants observed to be exposed and unexposed, or
E YjX0 ¼ 1
 
 EðY jX0 ¼ 0Þ. Note that, if we compute the
difference in the observed outcomes between exposed and
unexposed participants without regard to U, the true
causal effect of X on Y is obscured: the average EðYjX0
¼ 1Þ ¼ ð100 120þ 200 250Þ=ð100þ 200Þ ¼ 207, and
EðYjX0 ¼ 0Þ ¼ ð100  370þ 200 240Þ=ð100þ 200Þ ¼
283 such that the difference in average CD4 cell count be-
tween patients observed to be exposed and unexposed is
E YjX0 ¼ 1ð Þ  E YjX0 ¼ 0ð Þ ¼ 77. As noted above and
evident from the hidden-but-real data, the true causal ef-
fect of X on Y is 120. This is a demonstration of bias due
to confounding.7,8
Table 3 builds on Table 2 to demonstrate the effect of
introducing loss to follow-up, at a rate of 50%, among
participants with X ¼ 1, U ¼ 0 and 0% among others.
The outcome is not observed for participants who are
lost to follow-up. Using C as an indicator of loss to follow-
up, a complete case analysis of these data would
estimate the association between X and Y as
E YjX0 ¼ 1; C ¼ 0
 
 EðYjX0 ¼ 0; C ¼ 0Þ. The expected
value of Y among the unexposed, EðYjX0 ¼ 0; C ¼ 0Þ, can
be estimated as E YjX0 ¼ 0
 
above, and the expected value
of Y among the exposed is EðYjX0 ¼ 1; C ¼ 0Þ ¼ ð100
250þ 100 120Þ=ð100þ 100Þ ¼ 185. The effect esti-
mated by comparing the average CD4 cell count between
exposed and unexposed participants who remain in the
study is E YjX0 ¼ 1; C ¼ 0
 
 EðYjX0 ¼ 0;C ¼ 0Þ¼98.
The change in bias (which, by happenstance, makes our
observed point estimate less biased) is due to selection bias
(or, specifically, informative censoring).9
Table 4 introduces exposure measurement error on top
of the data presented in Table 3. Because exposure is a dis-
crete variable, we will refer to this measurement error as mis-
classification.10 In Table 4 the observed exposure X0 is a
misclassified version of X, with 80% sensitivity and 80%
specificity, and the misclassification of X is nondifferential
with respect to the outcome. Table 4 displays two rows for
each of four participant groups: the first row in each group-
pair are the 80% of participants who are correctly classified
with X
0 ¼ X; the second row in each group-pair are the 20%
of participants who are incorrectly classified with X
0 6¼ X.
Because the exposure misclassification was nondifferential
with respect to the outcome, Y is the same for the misclassi-
fied and correctly classified participants of each group.
Table 5 collapses Table 4 over the observed exposure
values X0 and shows only the data observed by investiga-
tors, subject to confounding, selection bias and exposure
misclassification. The mean CD4 count among participants
observed to be exposed (and not lost to follow-up) was
E YjX0 ¼ 1; C ¼ 0
 
¼ ð80 120þ 20 370þ 40 240
þ80 250Þ=ð80þ 20þ 40þ 80Þ¼ 212 cells/mm3, and the
mean CD4 count among the participants observed to be
unexposed was E YjX0 ¼ 0; C ¼

0Þ ¼ ð20 120þ 80
370þ 160 240þ 20 250Þ=ð20þ 80þ 160 þ 20Þ¼





C ¼ 0Þ ¼ 57 cells/mm3. As expected, simply
comparing outcomes between participants observed to be
exposed and observed to be unexposed does not provide
the correct estimate of the average treatment effect of
120 cells/mm3 obtained from the hidden potential out-
comes shown in Table 2.
Using the observed data provided in Table 5, an investiga-
tor may wish to estimate the causal effect of injection drug
use on CD4 cell count. Whereas the reader knows that
the quantity E YjX0 ¼ 1; C ¼ 0
 
 E YjX0 ¼ 0; C ¼

0Þ ¼
57 is biased by confounding, informative loss to follow-up
and exposure measurement error, the investigator has no
knowledge of the data-generating mechanism and wishes to
interpret the quantity E YjX0 ¼ 1; C ¼ 0
 
 E YjX0 ¼ 0;

C ¼ 0Þ ¼ 57 as the causal effect E½Y x ¼ 1ð Þ  Y x ¼ 0ð Þ.
Because the potential outcomes Y x ¼ 1ð Þ and Yðx ¼ 0Þ are
unobserved, we must impute potential outcomes for all par-
ticipants based on several untestable assumptions to estimate
the causal effect. The following sections guide the reader
through the process of performing the implicit imputations
required for causal inference.
Hidden imputations
We wish to compare the potential CD4 cell count 1 year
after therapy initiation had all individuals been exposed to
injection drug use, with the potential CD4 cell count had
all individuals been unexposed. Because true exposure
status and both potential outcomes are hidden for all par-
ticipants, we must impute these quantities before estimat-
ing a measure of effect. In Table 6, we use the notation X
to represent the exposure status we assume to be true in
the analysis. Similarly, Y x ¼ 1ð Þ and Y x ¼ 0ð Þ represent
the imputed potential CD4 cell count setting x ¼ 1 and
x ¼ 0, respectively. To impute X, Y x ¼ 1ð Þ and
Y x ¼ 0ð Þ for all participants in the study, we must make a
series of assumptions. Note that Table 6 presents the aver-
age value of the imputed potential outcomes E Y x ¼ xð Þ½ 
for each group but, as we discuss below, the imputations
are performed at the individual level. The first three
columns of imputed exposure and potential outcomes in
Table 6 illustrate that, prior to making these assumptions,
these quantities cannot be imputed.
No measurement error
As a first step, we must make an assumption about the ex-
posure status of each participant. We often assume that the
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observed exposure is measured without error and set
the exposure to be used in the analysis, X, equal to the
observed exposure X
0
. Note that X is not included in the
causal diagram in Figure 1 because the value of X (and its
relationship to other variables on the diagram) depends on
decisions and assumptions made by the investigator. In
Table 6, the first imputed column illustrates the assump-
tion of no measurement error by setting X ¼ X0 .
To link the observed outcomes to the hidden potential
outcomes, we let Y x ¼ 1ð Þ ¼ Y when X ¼ 1 and
Y x ¼ 0ð Þ ¼ Y when X ¼ 0, invoking counterfactual con-
sistency.11,12,13 Under the heading ‘assuming no measurement
error and invoking consistency,’ Table 6 shows the average of
the potential outcomes that would be imputed assuming no
measurement error and invoking consistency to link the
observed outcomes to the potential outcomes. Note that Y is
mapped to the incorrect potential outcome when X 6¼ X.
When information is available on the extent of the mis-
classification of exposure, such as an internal or external
validation subgroup, investigators may assign the value X
based on some function of X
0
and the misclassification
probabilities. The Appendix Table 1 (available as
Supplementary data at IJE online) illustrates the extreme
(and unlikely) situation in which investigators were able to
map exactly the observed exposure to the true exposure, so
that the value of the exposure used in the analysis, X, was
equal to the true exposure X.
Exchangeability
To impute both potential outcomes for the participants
who were lost to follow-up and the discordant potential
outcome for all participants (that is Y x ¼ 1ð Þ when X ¼ 0
and Y x ¼ 0ð Þ when X ¼ 1), we make an exchangeability
assumption.7,14 Viewing causal inference as a missing data
problem,5 we assume that the potential outcomes are miss-
ing at random, or that the value of the potential outcome
does not depend on its being observed. Based on the poten-
tial outcomes imputed so far in Table 6, we can see that
Y xð Þ is missing when C ¼ 1 or X 6¼ x.
To impute the potential outcomes for participants lost
to follow-up before the outcome was observed, we often
assume that the potential outcomes are independent of loss
to follow-up, given exposure. Assuming no informative
loss to follow-up (and, as above, no measurement error),
we impute Y x ¼ 1ð Þ as E YjX ¼ 1ð Þ and Y x ¼ 0ð Þ as E
YjX ¼ 0ð Þ for participants who became lost to the study.
Table 6 imputes the potential outcomes without regard to
unmeasured covariate U. If we were to measure U, we
could relax this assumption by assuming no informative
loss to follow-up conditional on U: To do this, we would
impute Y x ¼ 1ð Þ as E YjX ¼ 1; U ¼ uð Þ and Y x ¼ 0ð Þ
as E YjX ¼ 0; U ¼ uð Þ for participants who were lost to
follow-up with U ¼ u.
To impute the discordant potential outcome for each par-
ticipant (that is Y x ¼ 1ð Þ when X ¼ 0 and Y x ¼ 0ð Þ when
X ¼ 1), we sometimes assume that the potential outcomes
do not depend on the actual exposure received, or that there
is no confounding. Assuming no confounding (in addition to
no measurement error), we impute Y x ¼ 1ð Þ as E
YjX ¼ 1ð Þ when X ¼ 0 and Y x ¼ 0ð Þ as E YjX ¼ 0ð Þ
when X ¼ 1. Because covariate U is unmeasured in our
hypothetical study, Table 6 imputes the discordant potential
outcomes without regard to U. As above, if we were to
measure U, we could relax this assumption by assuming no
confounding conditional on U. To do this, we would impute
Y x ¼ 1ð Þ as E YjX ¼ 1; U ¼ uð Þ when X ¼ 0 and U ¼ u
and Y x ¼ 0ð Þ as E YjX ¼ 0; U ¼ uð Þ when X ¼ 1 and
U ¼ u,15 assuming positivity with respect to U:16 Further
discussion of the positivity assumption is reserved for the
Discussion.
With all potential outcomes imputed in the last column
of Table 6, the average of the difference in (imputed)
potential outcomes E½Y x ¼ 1ð Þ  Y x ¼ 0ð Þ can be com-
puted. Subtracting E½Y x ¼ 0ð Þ from E½Y x ¼ 1ð Þ and
taking a weighted average across all rows in Table 6, we
can see that, exactly as in Table 5, the results obtained in
Table 6 are incorrect. Because we incorrectly assumed no
measurement error, no confounding and no selection bias
in both Table 5 and Table 6, the estimated causal effect
from Table 6, E½Y x ¼ 1ð Þ  Y x ¼ 0ð Þ ¼ 57 cells/mm3,
matches the difference estimated by E YjX0 ¼ 1; C ¼ 0
 
E YjX0 ¼ 0; C ¼ 0
 
in Table 5. Thus, where Table 5
hides the imputations, Table 6 makes those imputations
explicit, but the (biased) result is identical.
Appendix Table 1 (available as Supplementary data at
IJE online) shows the results after performing these same
implicit imputations under a correct mapping of the
observed exposure to the true exposure, consistency, the
assumption of no selection bias conditional on U
(which we now assume to be measured) and the assump-
tion of no unmeasured confounding conditional on U.
Table 5. Average CD4 cell counts (EðY Þ) 1 year after therapy
initiation for 600 participants in a hypothetical study based
on observed injection drug use (X 0)
n X’ C E(Y)
220 1 0 212
280 0 0 269
80 1 1 ? a
20 0 1 ? a
a100 participants were lost to follow-up before CD4 cell count could be
measured.
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Because the assumptions used to perform the imputations
in Appendix Table 1 are correct, the average causal effect
estimated using the Appendix Table is E½Y x ¼ 1ð Þ  E½Y
x ¼ 0ð Þ ¼ 120 cells/mm3, which matches the true
causal effect E Y x ¼ 1ð Þ  Y x ¼ 0ð Þ½ , provided in Table 2.
Discussion
Here we have illustrated the implicit imputations that are
performed when estimating a causal effect from epidemiolo-
gical data. The example presented a situation common in
epidemiology: the exposure was misclassified, yet exposure
misclassification was assumed to be absent, an unmeasured
confounder was present and there was informative censor-
ing. In this example we can see that, though the crude
analysis performed using Table 5 seemed straightforward, it
was based on a series of hidden imputations based
on strong, untestable and in this case incorrect, assumptions
that were detailed in Table 6. The correct assumptions
and resultant imputations and analysis are provided in
the Appendix (available as Supplementary data at IJE
online).
Throughout the paper, we have referred to ‘hidden
imputations’ used by the investigator to make inferences
about causality. These imputations are rarely explicit. An
investigator faced with a two-by-two table or a regression
model, estimates an association between X and Y (perhaps
conditional on a set of factors) and interprets the associ-
ation as a causal relationship, has made these imputations,
though they are rarely acknowledged. Bias in epidemiolo-
gical analyses arises from differences between the unob-
served potential outcomes we wish to compare and the
potential outcomes we impute during the course of
data analysis. We expand on existing work by demonstrat-
ing how bias due to measurement error can be incorpo-
rated into the potential outcomes framework regularly
used to demonstrate bias due to confounding and
selection bias.
The imputation of potential outcomes may be per-
formed mentally to interpret an association estimated with
standard methods. Alternatively, one may use an explicit
imputation method, such as the g-formula. The latter is
typically preferable because it allows extension to perform
sensitivity analyses or to place bounds on the amount of
bias that could be expected from a given source (i.e. con-
founding, selection or measurement error).
In the example presented, exposure misclassification
was nondifferential with respect to the outcome. If mis-




would differ according to Y, and any function to
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here remains unchanged if misclassification is differential.
Note that we assumed that the outcome Y and confounder
U (when measured) were always recorded without error.
Error in the measurement of Y or U would further hinder
the ability of the investigator to link the observed outcome
to one of the potential outcomes.17 Similarly, we did not
examine the possibility of multiple versions of treatment.
Like the assumption of no measurement error, we gener-
ally assume treatment version irrelevance prior to linking
the observed outcomes to the potential outcomes by con-
sistency.11,12,13 In addition, we assumed that each partici-
pant’s potential outcomes did not depend on the exposures
of other participants, meaning that we did not explore vio-
lations of the assumption of no interference.18,19 Finally, in
the example presented here, we had positivity with respect
to U. Positivity requires that the causal effect of exposure
is estimable within each stratum of participants defined
by the confounders.16 In the analysis in which U was
measured (shown in Appendix Table 1, available as
Supplementary data at IJE online), if participants with U
¼ 1 were unable to be exposed (or if all participants with
U ¼ 1 were unexposed by chance), we would have been
unable to impute the potential outcomes Y x ¼ 1ð Þ condi-
tional on U for participants with U ¼ 1.
Here we have approached causal inference from the
paradigm of potential outcomes, though biases due to con-
founding, loss to follow-up, measurement error and miss-
ing data can also be conceptualized using causal directed
acyclic graphs.9,20–24 Single world intervention graphs25
offer a way forward to unify these approaches.
Traditional causal analyses begin with the premise that
investigators observe one potential outcome per partici-
pant. For example, with a binary exposure, many investi-
gators invoke consistency to claim that they observe the
potential outcome under exposure for a participant
observed to be exposed and the potential outcome under
no exposure for a participant observed to be unexposed. In
this scenario, half of the potential outcomes are missing.
However, by relaxing the assumption of no exposure
measurement error, we acknowledge our uncertainty about
which potential outcome we observe, so that we cannot
confidently ascribe values to any of the potential outcomes.
This additional uncertainty that arises when we acknow-
ledge the nonzero probability of measurement error in-
creases the amount of missing data in the potential
outcomes framework.
The example data used to illustrate how bias due to measure-
ment error fits into the potential outcomes framework was very
simple for pedagogic purposes. Although the average effect of in-
jection drug use on CD4 cell count was homogeneous with re-
spect to U, injection drug use may have had greater effect in
some participants and less effect in others. In fact, it is possible
that each ‘group’ included participants with a variety of causal
response types; in each group, some participants could have
been harmed by exposure, some could have been protected
and some could have experienced no change in CD4 cell count
due to exposure. The average treatment effect estimated here
can be seen as merely the average of all of the individual differ-
ences in potential outcomes Y x ¼ 1ð Þ  Yðx ¼ 0Þ.
We have examined three assumptions (no measurement
error, no selection bias and no confounding) through
which potential outcomes are casually, and often unknow-
ingly, imputed in epidemiology. Whereas studies attempt-
ing to establish causality rigorously assess and account for
confounding and selection bias, bias due to measurement
error is often ignored. Incorporating bias due to measure-
ment error into the potential outcomes framework will
help investigators identify and develop methods to address
measurement error in causal inference.
Supplementary Data
Supplementary data are available at IJE online.
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